Literature DB >> 27606097

Key management considerations in sarcoidosis from the American Thoracic Society 2016 Conference.

Ni-Cheng Liang1, Kim-Thuy Truong1, Kamyar Afshar1.   

Abstract

Entities:  

Year:  2016        PMID： 27606097      PMCID： PMC4990688          DOI： 10.21037/jtd.2016.07.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  12 in total

1.  An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment.

Authors:  M A Judson
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

Review 2.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

3.  An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.

Authors:  Simon Lf Walsh; Athol U Wells; Nicola Sverzellati; Gregory J Keir; Lucio Calandriello; Katerina M Antoniou; Susan J Copley; Anand Devaraj; Toby M Maher; Elizabetta Renzoni; Andrew G Nicholson; David M Hansell
Journal:  Lancet Respir Med       Date:  2014-01-15       Impact factor: 30.700

4.  Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.

Authors:  Catherine A Bonham; Justin M Oldham; Mardi Gomberg-Maitland; Rekha Vij
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

5.  Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.

Authors:  M K Park; H Babaali; L I Gilbert-McClain; M Stylianou; J Joo; J Moss; V C Manganiello
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

6.  Rituximab in the treatment of refractory pulmonary sarcoidosis.

Authors:  Nadera J Sweiss; Elyse E Lower; Mehdi Mirsaeidi; Steven Dudek; Joe G N Garcia; David Perkins; Patricia W Finn; Robert P Baughman
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

7.  Pentoxifylline in treatment of sarcoidosis.

Authors:  P Zabel; P Entzian; K Dalhoff; M Schlaak
Journal:  Am J Respir Crit Care Med       Date:  1997-05       Impact factor: 21.405

8.  Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis.

Authors:  R L M Mostard; S Vöö; M J P G van Kroonenburgh; J A Verschakelen; P A H M Wijnen; P J Nelemans; R J Erckens; M Drent
Journal:  Respir Med       Date:  2011-09-06       Impact factor: 3.415

9.  Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Authors:  Adriane D M Vorselaars; Wim A Wuyts; Veronique M M Vorselaars; Pieter Zanen; Vera H M Deneer; Marcel Veltkamp; Michiel Thomeer; Coline H M van Moorsel; Jan C Grutters
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

10.  Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Authors:  Edward S Chen; Zhimin Song; Matthew H Willett; Shannon Heine; Rex C Yung; Mark C Liu; Steve D Groshong; Ying Zhang; Rubin M Tuder; David R Moller
Journal:  Am J Respir Crit Care Med       Date:  2009-11-12       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.